Immunochromatographic test cassette based on a one-step in vitro test. It is designed for the rapid qualitative determination of the SARS-CoV-2 virus antigen in nasopharyngeal swabs from individuals suspected of COVID-19 by the healthcare provider within the first seven days of symptom onset. The Rapid SARS-CoV-2 Antigen Test Card cannot be used as a basis for the diagnosis or exclusion of SARS-CoV-2. Specificity: 99.16% (95%CI: 98.49%~99.83%) Sensitivity: 96.17% (95%CI: 94.04%~98.29%) Accuracy: 98.25% (95%CI: 97.44%~99.05%)